• Tioconazole: Assay Design at the Metabolic Edge

  2026-08-14

  Tioconazole is an antifungal medication with a defined cytochrome P450–ergosterol mechanism and practical value in controlled fungal assays. This article develops an assay-design framework that connects fungal pharmacology with metabolic-state controls while clearly separating established evidence from cross-domain inference.

• iPSC Cardiomyocyte Transcriptomics for Chemical Risk

  2026-08-14

  Tsai and colleagues show that combining functional phenotypes with whole-transcriptome responses in human iPSC-derived cardiomyocytes can strengthen chemical hazard identification and risk prioritization. The approach links concentration-response activity to mechanistic interpretation and bioactivity-to-exposure comparisons, while highlighting the complementary value and limitations of each data type.

• Protoporphyrin IX: From Heme to Ferroptosis

  2026-08-13

  Protoporphyrin IX is more than a heme biosynthetic intermediate: it is a photodynamic compound and a strategically useful probe for studying iron handling, oxidative stress, and cancer biology. This thought-leadership guide connects its photodynamic behavior with emerging ferroptosis research in hepatocellular carcinoma while defining the controls needed for credible translational experiments.

• Tioconazole Workflows for Antifungal Research

  2026-08-13

  Build reproducible Tioconazole screens around sterol-pathway biology, controlled solvent exposure, and orthogonal fungal readouts. This workflow positions the compound as a practical benchmark for antifungal drug development, resistance studies, and fungal infection model optimization.

• (+)-Bicuculline Workflow and QC Guide

  2026-08-12

  (+)-Bicuculline is a practical neuroscience research tool for probing GABAA receptor-mediated inhibition and related synaptic NMDA receptor signaling modulation. This guide covers solubilization, storage, assay controls, and interpretation boundaries; the compound is for scientific research only and should not be used for diagnostic, clinical, or therapeutic purposes.

• (+)-Bicuculline: Practical Protocol Guide

  2026-08-12

  This guide explains how to prepare, store, and quality-control (+)-Bicuculline for experiments that require controlled antagonism of GABAA-mediated signaling. It is a neuroscience research tool for laboratory use only and should not be used for diagnostic, therapeutic, or other medical applications.

• Geneticin Workflow for G418 Selection

  2026-08-11

  Build reproducible stable cell models with Geneticin, from kill-curve design through pathway validation. This guide also distinguishes G418 selection from exploratory Dengue virus inhibition, helping researchers choose defensible concentrations and controls.

• GSK J4 HCl: JMJD3 Inhibitor Evidence Guide

  2026-08-11

  GSK J4 HCl is a cell-permeable JMJD3 inhibitor and an ethyl ester derivative of GSK J1. Product-reported data support its use in histone demethylation, macrophage TNF-alpha assays, and SF8628 K27M xenograft research, while the decidual study provides mechanistic context rather than direct GSK J4 evidence.

• 0.4% Trypan Blue Solution: Technical Guide

  2026-08-10

  0.4% Trypan Blue Solution supports cell viability measurement and cell counting by staining dead or membrane-damaged cells blue while viable cells remain unstained. It is intended for research cell culture, viability, and cytotoxicity workflows, not for diagnostic or medical use.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer

  2026-08-09

  Zeng and colleagues developed a nonviral lipid nanoparticle system for intravesical delivery of chemically modified p21 mRNA, aiming to restore a tumor-suppressive cell-cycle checkpoint directly within bladder tumors. Their preclinical data connect localized mRNA expression with reduced tumor growth, altered cell-cycle signaling, DNA-damage accumulation, and apoptosis, while also highlighting the delivery and translational questions that remain.

• PLK1 Control of p31comet in Mitotic Checkpoint Exit

  2026-08-08

  The reference study identifies a regulatory connection between Polo-like kinase 1 and p31comet, showing that Plk1 phosphorylation restrains TRIP13-dependent disassembly of mitotic checkpoint complexes. This mechanism explains how an active spindle assembly checkpoint can avoid simultaneous MCC assembly and disassembly, while providing a framework for interpreting PLK1 inhibitor experiments.

• Single-Nucleus Profiling Reveals ATRNL1 in AF

  2026-08-07

  The reference study applies large-scale single-nucleus RNA sequencing to human left atrial tissue, resolving cell type-specific transcriptional changes associated with atrial fibrillation. Its functional experiments identify ATRNL1 as a cardiomyocyte-associated regulator of stress responses and cardiac electrical activity, providing a mechanistic starting point for AF research.

• MIZ1-TMBIM4 Axis Controls IgG1+ Germinal Center B Cell Selec

  2026-08-07

  This study delineates a unique transcriptional mechanism—MIZ1-driven TMBIM4 expression—that specifically safeguards IgG1+ germinal center (GC) B cells from apoptosis during positive selection. The findings clarify how BCR-mediated calcium signaling and mitochondrial integrity are differentially regulated among B cell isotypes, advancing our understanding of humoral immunity and providing new context for apoptosis signaling research.

• Cdc42 Inhibition Mitigates Kidney Fibrosis via β-Catenin Pat

  2026-08-06

  The reference study identifies Cdc42 as a central target in kidney fibrosis and demonstrates that a natural diterpenoid, daphnepedunin A, directly inhibits Cdc42 to disrupt pro-fibrotic β-catenin signaling. These findings suggest precise Cdc42 inhibition may offer a mechanistically rational approach for anti-fibrotic therapy and provide a foundation for using selective chemical inhibitors in kidney disease models.

• ECL Chemiluminescent Substrate Detection Kit: Optimizing Pro

  2026-08-06

  The ECL Chemiluminescent Substrate Detection Kit delivers high-sensitivity and reproducibility for Western blot chemiluminescence detection, empowering translational oncology research. Learn how to leverage this chemiluminescent substrate kit for robust protein and nucleic acid analysis, troubleshoot common pitfalls, and extract actionable insights from recent breakthroughs in RCC therapy.

683 records 8/46 page Previous Next First page 上5页 678910 下5页 Last page